International Stem Cell (ISCO) Net Cash Flow (2010 - 2025)
International Stem Cell's (ISCO) quarterly Net Cash Flow came in at $27000.0 in Q4 2025, up 135.06% year-over-year from $11486.2 in Q4 2024, and down 41.3% quarter-over-quarter from $46000.0 in Q3 2025.
Powered by 
Analysis
International Stem Cell (ISCO) Net Cash Flow (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Net Cash Flow for 16 consecutive years, with $27000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Cash Flow rose 135.06% year-over-year to $27000.0 in Q4 2025; TTM through Dec 2025 was -$37000.0, a 76.58% increase from a year earlier, with the FY2025 full-year figure at -$237000.0, up 33.8% from the prior year.
- Net Cash Flow was $27000.0 for Q4 2025 at International Stem Cell, down from $46000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $439000.0 in Q2 2023 and troughed at -$367000.0 in Q2 2021.
- A 5-year average of $35400.0 and a median of $62000.0 in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow slumped 680.85% in 2021 and jumped 352.08% in 2024, its largest moves.
- Over 5 years, Net Cash Flow stood at -$334000.0 in 2021, then soared by 122.75% to $76000.0 in 2022, then jumped by 107.89% to $158000.0 in 2023, then sank by 148.73% to -$77000.0 in 2024, then jumped by 135.06% to $27000.0 in 2025.
- The last three Net Cash Flow figures came in at $27000.0 (Q4 2025), $46000.0 (Q3 2025), and -$332000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -71.74 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -131.98 Mn |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | -85.58 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 26.80 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | 273.80 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -68.45 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 8.85 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.39 Bn | 251.87 Mn | 103.70 Mn |
| 9 | Vericel | 1.96 Bn | 1.79 Bn | 56.40 Mn | 16.06 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -332,000.00 |
| Mar 31, 2025 | 222,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | -96,000.00 |
| Mar 31, 2024 | -202,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 439,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | -334,000.00 |
| Sep 30, 2021 | -245,000.00 |
| Jun 30, 2021 | -367,000.00 |
| Mar 31, 2021 | 428,000.00 |